嵌合抗原受体
细胞毒性T细胞
淋巴因子激活杀伤细胞
免疫学
癌症
生物
NK-92
自然杀伤细胞
先天免疫系统
癌症研究
自然杀伤性T细胞
免疫疗法
白细胞介素21
癌症免疫疗法
细胞
移植排斥反应
免疫系统
移植
癌细胞
抗原
Janus激酶3
细胞毒性
先天性淋巴细胞
医学
受体
作者
Marjorie Cayatte,Valentin Picant,Marie Vétizou,Éric Vivier
摘要
Natural killer (NK) cells are cytotoxic and cytokine-producing innate lymphocytes with established roles in antiviral and antitumor immunity. In recent years, the biology of NK cells has been exploited in innovative cancer immunotherapies, leading to clinical advances including allogeneic NK cell infusions, chimeric antigen receptor NK cells, and NK cell engager technologies. These studies pave the way to explore how advances in NK cell-based immunotherapies could be leveraged outside of oncology to selectively target pathogenic cells and restore tissue homeostasis in viral infections, neurodegenerative disorders, autoimmunity, and transplantation medicine.
科研通智能强力驱动
Strongly Powered by AbleSci AI